1. Home
  2. NPKI vs CSTL Comparison

NPKI vs CSTL Comparison

Compare NPKI & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

HOLD

Current Price

$13.65

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$40.94

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
CSTL
Founded
1932
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NPKI
CSTL
Price
$13.65
$40.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$14.17
$46.00
AVG Volume (30 Days)
544.1K
335.2K
Earning Date
02-25-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
N/A
Revenue
$259,372,000.00
$343,530,000.00
Revenue This Year
$26.96
$2.54
Revenue Next Year
$13.16
N/A
P/E Ratio
$35.83
N/A
Revenue Growth
25.65
10.15
52 Week Low
$4.76
$14.59
52 Week High
$14.00
$42.18

Technical Indicators

Market Signals
Indicator
NPKI
CSTL
Relative Strength Index (RSI) 66.90 64.41
Support Level $12.04 $38.73
Resistance Level $12.56 $41.88
Average True Range (ATR) 0.40 1.49
MACD 0.15 -0.14
Stochastic Oscillator 81.82 81.05

Price Performance

Historical Comparison
NPKI
CSTL

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: